封面
市場調查報告書
商品編碼
1198717

陰道回春市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Vaginal Rejuvenation Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

陰道修復市場預計在 2022 年至 2027 年的預測期內以 10.4% 的複合年增長率增長。

預計 COVID-19 對陰道修復市場的影響與其他行業一樣大。 由於交通限制和對病毒感染的恐懼,全球大多數人推遲了整容手術,整容手術行業受到了負面影響。 正因為如此,陰道回春治療等整容手術也被推遲。 根據國際美容整形外科學會 2020 年的報告,2020 年進行了 142,119 例陰唇整形手術。 研究發現,2020 年進行的手術數量比上一年減少了 13.7%。 此外,根據發表在《2020 年美容整形外科》雜誌上的一篇研究論文,在與 COVID-19 大流行相關的經濟衰退中,患者的財務限制和無力支付整容手術的費用有所增加,導致手術越來越小。 因此,考慮到上述因素,陰道回春市場受到了大流行的影響。

推動市場增長的關鍵因素包括越來越多地採用無創婦科手術、改變女性的生活方式以及對基於能量的治療的需求激增。 尿失禁、盆腔器官脫垂等盆底疾病的發生率隨著年齡的增長而顯著增加。 這些疾病發病率的增加正在推動市場,因為它們可以通過陰道回春療法治愈。 科學報告 2022 年 6 月的一項題為“在初級保健機構中觀察到的成年女性盆底疾病患病率和相關風險因素”的研究顯示,美國約四分之一的女性患有盆底疾病。據說他患有殘疾。 80 歲以上的女性盆底疾病的發病率也增加了 2 倍。

此外,隨著女性整容手術等意識的提高,以及全球可支配收入的增加,預計該市場將得到提振。 Viveve 和 Geneve 等射頻治療的日益普及也是市場的主要驅動力。 由於它們的非侵入性以及在單個程序中獲得結果的能力,這些治療的需求量很大。 這種治療有助於改善陰道組織 (Viveve) 的血液循環,並在 30 分鐘內刺激天然膠原蛋白的形成過程 (Geneve)。 因此,提高對這些療法的認識正在為預測期內研究的市場創造有利可圖的機會。

陰道緊縮市場趨勢

估計並預計陰道整容手術部分將在預測期內實現有利增長。

由於對陰道成形術、大陰唇、陰蒂罩縮小術、陰唇成形術和陰唇成形術的需求不斷增長,預計未來陰道整容手術將呈現健康增長。 根據國際美容整形外科學會 2020 年的報告,2020 年共進行了 142,119 例陰唇整形手術,佔全球整形外科醫生進行的所有外科手術的 1.4%。

能量療法是一種非手術的陰道修復方法。 目前,兩種類型的基於能量的治療用於陰道回春:射頻 (RF) 治療和 CO2 激光治療。 在射頻治療方案中,電磁波用於加熱組織,這些設備的示例包括 Viveve 的 Geneve 和 ThermiVa。 同樣,CO2 激光療法使用激光加熱組織的上層。 這允許底層組織合成更多的膠原蛋白,從而使皮膚更緊緻、更緊緻。 使用 CO2 激光技術的設備示例包括 MonaLisa Touch、FemTouch 和 FemiLift。 多年來,在提供具有更好功能的改進產品以獲得卓越結果方面,越來越多的技術進步推動了研究市場的發展。 因此,由於陰唇整形術的高發生率以及微創手術的意識和採用率不斷提高,預計在預測期內,美容陰道年輕化領域將會增長。

有一篇文章題為“陰道回春的策略:二氧化碳激光還是陰道成形術?” 陰道回春手術和非手術方法的比較,發表於 2021 年 4 月的《轉化醫學年鑑》。 該研究表明,重度和中度陰道鬆弛需要手術治療,非手術治療足以治療輕度陰道鬆弛。 此類專注於陰道回春的研究可能會在預測期內推動市場增長。

北美佔有很大的市場份額,預計在預測期內也會如此

由於消費者的高可支配收入導致陰道手術的增加,預計北美將在陰道回春市場佔據很大份額。 對陰唇整形術的需求不斷增長、現代技術的日益普及以及整形外科醫生數量的增加也是推動該地區市場增長的因素。 此外,微創和非侵入性女性健康方式的趨勢以及美國女性對整容手術的興趣日益增長也在推動市場。 根據美國整形外科醫師學會2020年的報告,2020年美國共進行了9725例陰唇整形手術,佔全國整容手術總數的4.19%。

在 2021 年 12 月發表在《性醫學雜誌》上的題為“ThermiVa In Genital Hiatus Treatment (TIGHT) Study”的論文中,正在考慮 ThermiVa 設備在治療外陰鬆弛和性功能障礙方面的有效性和安全性。 ThermiVa是美國Thermi Aesthetics公司生產的外陰鬆弛和性功能障礙治療儀。 該論文表明,該裝置與陰道鬆弛和性功能障礙的改善有關。 此類設備在美國很受歡迎,預計會刺激市場增長。

此外,幾個主要的市場參與者在市場增長中發揮著關鍵作用。 例如,2020 年 12 月,Viveve Medical Inc. 獲得了美國食品和藥物管理局 (FDA) 頒發的 510 許可證,以擴大其可與 Viveve 的低溫冷卻單極射頻 (CMRF) 技術配合使用的消耗性治療芯片的製造能力。 (k) 獲得授權;

因此,由於上述因素,預計陰道回春市場將會增長。

陰道緊縮市場競爭對手分析

陰道修復市場高度整合,由幾家主要參與者組成。 目前主導市場的公司包括 Lutronic、ThermiGen、Alma Lasers、Viveve、VenusConcept 和 Hologic。 公司正在通過各種戰略發展,例如投資研發活動、收購和資產剝離,以確保其在全球市場中的地位。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動力
    • 對能量療法的需求激增
    • 擴大採用無創婦科手術
    • 女性生活方式的改變
  • 市場製約因素
    • 對以能量為基礎的婦科手術有嚴格的規定
    • 與婦科手術相關的社會污名
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分(基於金額,單位:百萬美元)

  • 按治療類型
    • 美容美陰
      • G 點放大
      • 陰唇整形術
      • 食物切除術
      • 處女膜成形術
    • 陰道回春
      • 陰道成形術
      • 會陰整形術
  • 地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Lutronic
    • ThermiGen LLC
    • Alma Lasers
    • Almirall
    • Viveve
    • VenusConcept
    • Hologic
    • BTL Group Companies
    • Fotona

第7章 市場機會與今後動向

簡介目錄
Product Code: 68958

The vaginal rejuvenation market is expected to register a CAGR of 10.4% over the forecast period, 2022-2027.

The impact of COVID-19 on the vaginal rejuvenation market is predicted to be significant just like any other sector. The cosmetic surgery industry has witnessed a negative impact as most of the populations across the globe deferred aesthetic surgeries due to restrictions on transportation and owing to the fear of viral infection. This has also resulted in the postponement of cosmetic procedures, which included vaginal rejuvenation treatments as well. As per the International Society of Aesthetic Plastic Surgery's 2020 report, the number of labiaplasty procedures performed in the year 2020 was 142,119. The number of surgeries performed in 2020 showed a 13.7% decrease from the number of surgeries performed in the previous year. Additionally, as per the research article published in Aesthetic Plastic Surgery, 2020, the financial constraints and the inability to pay for aesthetic procedures by patients during the COVID-19 pandemic-related economic recession have led to a downtrend in plastic and cosmetic surgeries globally. Thus, given the aforementioned factors, the vaginal rejuvenation market has been impacted by the pandemic.

The major factors attributing to the growth of the market include increasing adoption of non-invasive gynecological procedures, changing women's lifestyles, and surging demand for energy-based treatments. The incidences of pelvic floor disorders, such as urinary incontinence, pelvic organ prolapse, and a few more, significantly increase with age. Increasing incidences of these disorders drive the market as these disorders can be cured by vaginal rejuvenation treatment. As per an article titled "Prevalence of pelvic floor disorders in adult women being seen in a primary care setting and associated risk factors" published in the journal Scientific Reports in June 2022, around one-fourth of the women in the United States suffer from a pelvic floor disorder. The rate of incidence of a pelvic floor disorder doubled in women over the age of 80 years old.

Moreover, rising awareness about cosmetic surgical procedures such as female cosmetic genital surgery, along with rising disposable income around the world, is anticipated to boost the market. Also, the increasing popularity of radio frequency-based treatments such as Viveve and Geneveve are key driving factors for the market as these treatments are in huge demand for their features such as non-invasive nature and single session results. This treatment helps in improving the blood circulation of vaginal tissue (Viveve) and stimulates the natural collagen formation process in 30 minutes (Geneveve). Thus, the rising awareness about these treatments is creating a lucrative opportunity for the studied market over the forecast period.

Vaginal Rejuvenation Market Trends

The Cosmetic Vaginal Rejuvenation Segment is Estimated to Witness Healthy Growth Over the Forecast Period

Cosmetic vaginal rejuvenation is estimated to witness healthy growth in the future attributing to the rising demand for vaginoplasty, labia majoraplasty, clitoral hood reduction, labiaplasty, and monsplasty. According to the International Society of Aesthetic Plastic Surgery, 2020 report, a total of 142,119 labiaplasty procedures were performed, accounting for 1.4% of all surgical procedures performed by plastic surgeons worldwide, in 2020.

The energy-based treatment procedures are non-surgical methods for vaginal rejuvenation. Two types of energy-based treatments are being performed currently in vaginal rejuvenation, namely, radiofrequency (RF) treatment and CO2 laser treatment. In the radiofrequency treatment protocol, electromagnetic radiations are used to heat the tissue, and examples of these devices include Geneveve by Viveve and ThermiVa. Similarly, the CO2 laser treatment employs laser light that heats the upper layer of the tissue. This will enable the tissues in the lower layer to synthesize more collagen, thus making the skin firm and tight. Examples of devices that work on CO2 laser technology include MonaLisa Touch, FemTouch, and FemiLift. The increasing technological advancements in providing improved products with better features for outstanding results have been driving the studied market over the years. Thus, with the high incidence of labiaplasty procedures being performed along with the increasing awareness and adoption of minimally invasive surgeries, the cosmetic vaginal rejuvenation segment is expected to grow over the forecast period.

An article titled "The strategy for vaginal rejuvenation: CO2 laser or vaginoplasty?" presented in the journal of Annals of Translational Medicine in April 2021 compared the surgical and non-surgical methods for vaginal rejuvenation. The study declared that surgical treatment is necessary for severe- and moderate-degree vaginal laxity and non-surgical treatment is sufficient for light-degree vaginal laxity. Such studies focusing on vaginal rejuvenation are likely to boost the market growth over the forecast period.

North America Holds a Significant Share in the Market and is Expected to do the Same over the Forecast Period

North America is expected to hold a significant share in the vaginal rejuvenation market due to the increasing number of vaginal procedures with the high disposable income of consumers. The rising demand for labiaplasty, increasing adoption of modern technologies, and the growing number of plastic surgeons are also factors promoting market growth in this region. Furthermore, the inclination toward minimally invasive and non-invasive women's health procedures and the increasing interest in aesthetic procedures among women in the United States drive the market. According to the American Society of Plastic Surgeons, 2020 report, a total of 9,725 labiaplasty procedures were performed in the United States in 2020, accounting for 4.19% of the total cosmetic surgical procedures in the nation.

An article titled "The ThermiVa In Genital Hiatus Treatment (TIGHT) Study" published in the Journal of Sexual Medicine in December 2021 studied the efficacy and safety of the device, ThermiVa, a device in the treatment of vulvovaginal laxity and sexual dysfunction. ThermiVa is a device manufactured by ThermiAesthetics in the United States, for the treatment of vulvovaginal laxity and sexual dysfunction. The article indicated that the device was associated with an improvement in vaginal laxity and sexual dysfunction. The prevalence of such devices in the United States is likely to add to the growth of the market.

Several key market players are also playing an important role in the growth of the market. For instance, in December 2020, Viveve Medical Inc. received 510(k) clearance by the United States Food and Drug Administration (FDA) to expand the manufacturing capacity for its consumable treatment tips, which can be employed with Viveve's Cryogen-cooled Monopolar Radiofrequency (CMRF) technology.

Therefore, due to the aforementioned factors, the vaginal rejuvenation market is expected to grow.

Vaginal Rejuvenation Market Competitor Analysis

The vaginal rejuvenation market is highly consolidated and consists of few major players. Some of the companies currently dominating the market are Lutronic, ThermiGen, Alma Lasers, Viveve, VenusConcept, and Hologic. The companies are evolving through various strategies such as investments in research and development activities, acquisitions, and divestitures to secure their positions in the global market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Surging Demand for Energy Based Treatments
    • 4.2.2 Increasing Adoption of Non-invasive Gynecological Procedures
    • 4.2.3 Changing Lifestyles of Women
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulations for Energy Based Gynecological Procedures
    • 4.3.2 Social Stigma Associated with Gynecological Procedures
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - in USD Millions)

  • 5.1 By Treatment Type
    • 5.1.1 Cosmetic Vaginal Rejuvenation
      • 5.1.1.1 G-spot Amplification
      • 5.1.1.2 Labiaplasty
      • 5.1.1.3 Hoodectomy
      • 5.1.1.4 Hymenoplasty
    • 5.1.2 Reconstructive Vaginal Rejuvenation
      • 5.1.2.1 Vaginoplasty
      • 5.1.2.2 Perineoplasty
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle-East
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle-East
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Lutronic
    • 6.1.2 ThermiGen LLC
    • 6.1.3 Alma Lasers
    • 6.1.4 Almirall
    • 6.1.5 Viveve
    • 6.1.6 VenusConcept
    • 6.1.7 Hologic
    • 6.1.8 BTL Group Companies
    • 6.1.9 Fotona

7 MARKET OPPORTUNITIES AND FUTURE TRENDS